Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-31 @ 1:36 PM
Study NCT ID:
NCT05979051
Status:
RECRUITING
Last Update Posted:
2025-12-04
First Post:
2023-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）
Sponsor:
Guangdong Hengrui Pharmaceutical Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2028-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-30
First Submit QC Date:
None
Study First Post Date:
2023-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-26
Last Update Post Date:
2025-12-04
Last Update Post Date Type:
ESTIMATED